S&P 및 Nasdaq 내재가치 문의하기

MediciNova, Inc. MNOV NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 MediciNova, Inc. (MNOV), 포함 35 건 매수11 건 매도. 내부자 매수 총액은 $14.79M 내부자 매도 총액은 $824.22K.

최근 활동이 있는 주요 내부자에는 Iwaki Yuichi, Matsuda Kazuko, Nagao Hideki. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — MNOV

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2026-01-16 Iwaki Yuichi President and CEO RSU 부여 450,000 $2.10 $945K 450,000
2026-01-16 Matsuda Kazuko Chief Medical Officer RSU 부여 350,000 $2.10 $735K 350,000
2025-06-17 Nagao Hideki Director RSU 부여 20,000 $1.26 $25.2K 20,000
2025-06-17 Beaver Carolyn Director RSU 부여 20,000 $1.26 $25.2K 20,000
2025-06-17 Lemerond Nicole Director RSU 부여 20,000 $1.26 $25.2K 20,000
2025-02-12 Iwaki Yuichi President and CEO RSU 부여 100,000 $1.84 $184K 100,000
2025-02-12 Nagao Hideki Director RSU 부여 24,500 $1.84 $45.08K 24,500
2025-02-12 Beaver Carolyn Director RSU 부여 24,500 $1.84 $45.08K 24,500
2025-02-12 Matsuda Kazuko Chief Medical Officer RSU 부여 100,000 $1.84 $184K 100,000
2025-02-12 Lemerond Nicole Director RSU 부여 24,500 $1.84 $45.08K 24,500
2025-01-07 Iwaki Yuichi President and CEO RSU 부여 400,000 $1.52 $608K 400,000
2025-01-07 Matsuda Kazuko Chief Medical Officer RSU 부여 300,000 $1.52 $456K 300,000
2024-06-11 Nagao Hideki Director RSU 부여 20,000 $1.34 $26.8K 20,000
2024-06-11 Beaver Carolyn Director RSU 부여 20,000 $1.34 $26.8K 20,000
2024-06-11 Lemerond Nicole Director RSU 부여 20,000 $1.34 $26.8K 20,000
2024-01-09 Iwaki Yuichi President and CEO RSU 부여 210,000 $2.40 $504K 210,000
2024-01-09 Matsuda Kazuko Chief Medical Officer RSU 부여 157,500 $2.40 $378K 157,500
2024-01-09 Obrien Geoffrey Vice President RSU 부여 84,000 $2.40 $201.6K 84,000
2023-08-04 Lemerond Nicole Director 알 수 없음 - - - -
2023-08-04 Lemerond Nicole Director RSU 부여 18,333 $2.47 $45.28K 18,333
2023-06-13 Nagao Hideki Director RSU 부여 20,000 $2.23 $44.6K 20,000
2023-06-13 Beaver Carolyn Director RSU 부여 20,000 $2.23 $44.6K 20,000
2023-01-23 Iwaki Yuichi President and CEO RSU 부여 235,125 - - 235,125
2023-01-23 Matsuda Kazuko Chief Medical Officer RSU 부여 149,625 - - 149,625
2023-01-23 Obrien Geoffrey Vice President RSU 부여 76,950 - - 76,950
2022-11-28 Nagao Hideki Director 정보 매도 6,754 $2.25 $15.2K -
2022-11-22 Nagao Hideki Director 정보 매도 218 $2.13 $464.34 6,754
2022-11-21 Nagao Hideki Director 정보 매도 5,365 $2.18 $11.7K 6,972
2022-11-17 Nagao Hideki Director 정보 매도 309 $2.18 $673.62 12,337
2022-06-16 Nagao Hideki Director RSU 부여 20,000 - - 20,000
2022-06-16 Beaver Carolyn Director RSU 부여 20,000 $2.51 $50.2K 20,000
2022-06-16 Kruger Jason J Officer 알 수 없음 - - - -
2022-01-27 Iwaki Yuichi President and CEO RSU 부여 302,500 $5.92 $1.79M 302,500
2022-01-27 Matsuda Kazuko Chief Medical Officer RSU 부여 192,500 $5.92 $1.14M 192,500
2022-01-27 Obrien Geoffrey Vice President RSU 부여 99,000 $5.92 $586.08K 99,000
2021-08-23 Matsuda Kazuko Chief Medical Officer 옵션 행사 (매도) 60,000 $2.30 $138K -
2021-08-01 Paulin Douglas Officer 알 수 없음 - - - -
2021-07-09 Iwaki Yuichi President and CEO 옵션 행사 (매도) 39,583 $2.54 $100.54K -
2021-06-24 Matsuda Kazuko Chief Medical Officer 옵션 행사 (매도) 56,250 $2.46 $138.38K -
2021-06-16 Nagao Hideki Director RSU 부여 20,000 $3.95 $79K 20,000
2021-06-16 Beaver Carolyn Director RSU 부여 20,000 $3.95 $79K 20,000
2021-05-19 Obrien Geoffrey Vice President 옵션 행사 (매도) 32,000 $2.54 $81.28K -
2021-04-22 Gaeta Federico C.a. Chief Scientific Officer 처분 20,000 $5.42 $108.4K -
2021-04-22 Gaeta Federico C.a. Chief Scientific Officer RSU 부여 24,000 $4.56 $109.44K 24,000
2021-03-11 Nagao Hideki Director 정보 매도 2,354 $7.40 $17.42K 12,646
2021-02-25 Iwaki Yuichi President and CEO 옵션 행사 (매도) 86,250 $2.46 $212.18K -
2021-02-02 Iwaki Yuichi President and CEO RSU 부여 495,000 $6.89 $3.41M 495,000
2021-02-02 Matsuda Kazuko Chief Medical Officer RSU 부여 325,000 $6.89 $2.24M 325,000
2021-02-02 Obrien Geoffrey Vice President RSU 부여 99,000 $6.89 $682.11K 99,000
2021-01-11 3d Investment Partners Pte. Ltd. 10 Percent Owner 알 수 없음 456,637 - - -
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기